Baiyu serves an integral chain of pharmaceutical R&D, manufacture and sales with about 1,000 personnel. Baiyu has 3 production lines that meet the latest Chinese GMP requirement. Meanwhile a new site named GKL is to be commissioned soon, which covers 110,000m2 floorage and is based on EU and US GMP with an annual capacity of 100 million freeze-dried injectables and 120 million liquid injectables. Main products include enoxaparin sodium injection & for injection, ginkgolide injection, pantoprazole sodium for injection, etc. We are seeking partners to win a global presence for our products, and offer CMO service as well.